Fat molecule clues could improve anorexia treatment

NCT ID NCT06800937

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at specific fat molecules (sphingolipids) in the blood of women with anorexia nervosa. Researchers will compare these molecules between patients and healthy women, and see how they relate to hormone levels and mood. The goal is to find patterns that could lead to better diet plans and long-term treatment success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could point toward better dietary strategies in rehabilitation programs for anorexia nervosa.

What could go wrong

This is an observational study with only 60 participants, so results may not apply to all patients. It measures biomarkers, not treatment outcomes, so direct benefits are uncertain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANOREXIA NERVOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anorexia nervosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Istituto Auxologico Italiano IRCCS, Site Piancavallo

    RECRUITING

    Oggebbio, Verbania, 28824, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••